Abstract
A total of 33 clinical isolates of Capnocytophaga spp. were susceptible to 4-quinolone antimicrobial agents. The antipseudomonal penicillins tested were equally active against all isolates, as were cefuroxime, ceftriaxone, ceftizoxime, cefotaxime, latamoxef, and ceftazidime. Most isolates were resistant to trimethoprim, and some were resistant to aztreonam. Most regimens for the empirical treatment of septic episodes in immunocompromised patients are suitable for the treatment of Capnocytophaga spp. infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chantot J. F., Bryskier A. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison. J Antimicrob Chemother. 1985 Oct;16(4):475–484. doi: 10.1093/jac/16.4.475. [DOI] [PubMed] [Google Scholar]
- Forlenza S. W., Newman M. G., Horikoshi A. L., Blachman U. Antimicrobial susceptibility of Capnocytophaga. Antimicrob Agents Chemother. 1981 Jan;19(1):144–146. doi: 10.1128/aac.19.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forlenza S. W., Newman M. G., Lipsey A. I., Siegel S. E., Blachman U. Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients. Lancet. 1980 Mar 15;1(8168 Pt 1):567–568. doi: 10.1016/s0140-6736(80)91057-0. [DOI] [PubMed] [Google Scholar]
- Hawkey P. M., Malnick H., Glover S. A., Cook N., Watts J. A. Capnocytophaga ochracea infection: two cases and a review of the published work. J Clin Pathol. 1984 Sep;37(9):1066–1070. doi: 10.1136/jcp.37.9.1066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mycock G., Azadian B. S. Capnocytophaga ochracea: an unusual opportunistic pathogen. J Clin Pathol. 1985 Sep;38(9):1081–1082. doi: 10.1136/jcp.38.9.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parenti D. M., Snydman D. R. Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. J Infect Dis. 1985 Jan;151(1):140–147. doi: 10.1093/infdis/151.1.140. [DOI] [PubMed] [Google Scholar]
- Socransky S. S., Holt S. C., Leadbetter E. R., Tanner A. C., Savitt E., Hammond B. F. Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization. Arch Microbiol. 1979 Jul;122(1):29–33. doi: 10.1007/BF00408042. [DOI] [PubMed] [Google Scholar]
- Sutter V. L., Pyeatt D., Kwok Y. Y. In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents. Antimicrob Agents Chemother. 1981 Aug;20(2):270–271. doi: 10.1128/aac.20.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983 Apr;23(4):559–564. doi: 10.1128/aac.23.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]